AU2002223013A1 - Pharmaceutical oxaliplatinum preparation for parenteral administration and method for obtaining same - Google Patents
Pharmaceutical oxaliplatinum preparation for parenteral administration and method for obtaining sameInfo
- Publication number
- AU2002223013A1 AU2002223013A1 AU2002223013A AU2301302A AU2002223013A1 AU 2002223013 A1 AU2002223013 A1 AU 2002223013A1 AU 2002223013 A AU2002223013 A AU 2002223013A AU 2301302 A AU2301302 A AU 2301302A AU 2002223013 A1 AU2002223013 A1 AU 2002223013A1
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical
- parenteral administration
- obtaining same
- oxaliplatinum
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title 1
- 238000007911 parenteral administration Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH2422/00 | 2000-12-12 | ||
| CH24222000 | 2000-12-12 | ||
| PCT/CH2001/000708 WO2002047725A2 (en) | 2000-12-12 | 2001-12-12 | Pharmaceutical oxaliplatinum preparation for parenteral administration and method for obtaining same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002223013A1 true AU2002223013A1 (en) | 2002-06-24 |
Family
ID=4569152
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002223013A Abandoned AU2002223013A1 (en) | 2000-12-12 | 2001-12-12 | Pharmaceutical oxaliplatinum preparation for parenteral administration and method for obtaining same |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US7012072B2 (en) |
| EP (1) | EP1341555A2 (en) |
| AU (1) | AU2002223013A1 (en) |
| WO (1) | WO2002047725A2 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040022842A1 (en) * | 2002-06-03 | 2004-02-05 | Mebiopharm Co., Ltd. | Liposome preparations containing oxaliplatin |
| US20060063833A1 (en) * | 2004-09-22 | 2006-03-23 | Edgar Schridde | Ready-to-use oxaliplatin solutions |
| US20060063720A1 (en) * | 2004-09-22 | 2006-03-23 | Edgar Schridde | Oxaliplatin solution concentrate |
| JP2006248978A (en) | 2005-03-10 | 2006-09-21 | Mebiopharm Co Ltd | New liposome preparation |
| DE102005038347A1 (en) * | 2005-08-11 | 2007-02-15 | Hexal Ag | Preparation of an oxaliplatin solution and container and container set with the solution |
| US20090076139A1 (en) * | 2007-09-19 | 2009-03-19 | Protia, Llc | Deuterium-enriched oxalplatin |
| AU2010296180B2 (en) | 2009-09-21 | 2016-05-05 | Bio-Synectics, Inc | Oxaliplatin nanoparticles and method for preparing same |
| JP5314790B1 (en) * | 2012-07-09 | 2013-10-16 | 東和薬品株式会社 | Oxaliplatin-containing pharmaceutical composition |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4439181A (en) * | 1981-01-26 | 1984-03-27 | Regents Of The University Of Minnesota | Polyol-hormone mixture for use in chronic parenteral hormone administration |
| AU5416394A (en) | 1992-11-24 | 1994-06-22 | Debiopharm S.A. | Cisplatinum/oxaliplatinum combination |
| US5705180A (en) * | 1993-03-22 | 1998-01-06 | Betatene Limited | Therapeutic agent for the treatment of melanomas |
| KR100365171B1 (en) | 1994-08-08 | 2003-02-19 | 드바이오팜 에스.아. | Pharmaceutically stable oxaliplatinum preparation |
| AU6178198A (en) | 1997-03-07 | 1998-09-22 | Sanofi Pharmaceuticals, Inc. | Method of treating a tumor |
| GB9804013D0 (en) * | 1998-02-25 | 1998-04-22 | Sanofi Sa | Formulations |
| WO2000021527A2 (en) * | 1998-10-14 | 2000-04-20 | Debiopharm S.A. | Oxaliplatinum preparation packaging |
| BRPI0013613B8 (en) * | 1999-08-30 | 2021-05-25 | Debiopharm Sa | pharmaceutically stable composition of oxaliplatin for parenteral administration. |
-
2001
- 2001-12-12 EP EP01270345A patent/EP1341555A2/en not_active Ceased
- 2001-12-12 US US10/450,260 patent/US7012072B2/en not_active Expired - Lifetime
- 2001-12-12 AU AU2002223013A patent/AU2002223013A1/en not_active Abandoned
- 2001-12-12 WO PCT/CH2001/000708 patent/WO2002047725A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002047725A2 (en) | 2002-06-20 |
| WO2002047725A3 (en) | 2002-10-10 |
| US7012072B2 (en) | 2006-03-14 |
| EP1341555A2 (en) | 2003-09-10 |
| US20040127557A1 (en) | 2004-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU6271401A (en) | Drug administering system and administering method | |
| AU3403201A (en) | Drug delivery device and method | |
| AU2002252152A1 (en) | Tissue electroperforation for enhanced drug delivery and sampling | |
| AU2002236647A1 (en) | Method and device for administering medication and/or placebo | |
| AU2001240753A1 (en) | Lipid nanocapsules, preparation method and use as medicine | |
| AU2001294808A1 (en) | Catecholamine pharmaceutical compositions and methods | |
| AU1267400A (en) | Pharmaceutical moxifloxacin preparation | |
| AU2002239397A1 (en) | Drug formulation having improved oral tolerability | |
| AU2001226029A1 (en) | Pharmaceutical formulation and method for pulmonary and oral delivery | |
| AU2001284444A1 (en) | Preparations for oral administration | |
| AU5686400A (en) | Method for producing quickly decomposable solid pharmaceutical preparations | |
| IL145559A0 (en) | Tolperison-containing pharmaceutical preparation for oral administration | |
| AU777185C (en) | Pharmaceutical form of administration for peptides, methods for its production and use | |
| HUP0300334A3 (en) | Pharmaceutical preparations and their manufacture | |
| AU2002234545A1 (en) | Pharmaceutical preparation in the form of a suspension comprising an acid-labileactive ingredient | |
| AU2002217229A1 (en) | Pharmaceutical dronedarone composition for parenteral administration | |
| AU2002223013A1 (en) | Pharmaceutical oxaliplatinum preparation for parenteral administration and method for obtaining same | |
| HUP0303597A3 (en) | Diposable vaginal cannula for the simultaneous administration of drugs in different forms | |
| AU2001254812A1 (en) | 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations | |
| AU2001293907A1 (en) | Method for preparing camptothecin and its derivatives | |
| AU3926000A (en) | Methods and compositions for drug delivery | |
| AU2001241060A1 (en) | Gel preparations for oral administration having improved preservation properties | |
| AU5483600A (en) | Pharmaceutical materials and methods for their preparation and use | |
| AU1172101A (en) | Phytoestrogenic pharmaceutical preparations | |
| AU2001228784A1 (en) | Inositol derivatives and their pharmaceutical use |